Intellectual Property Magazine
GSK deal with generics may ‘abuse’ EU competition laws
Ben Wodecki
Agreements between patent holders and generic manufactures to not enter a specific market may break EU competition law, a
Court of Justice for the European Union (CJEU) advocate general has opined.